Vaccine-Pembrolizumab Combo Appears Active in HPV+ Advanced Cervical Cancer

The GX-188E vaccine and pembrolizumab can elicit responses in patients with HPV 16-/18-positive advanced cervical cancer.

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Korea ,Jong Lee ,Catholic University Of Korea ,Sung Jong Lee ,Catholic University ,